FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, specifically to ophthalmology, and is intended for local administration of ophthalmic multi-dose aqueous composition in eye of a mammal. Said composition contains a therapeutically effective amount of a therapeutic agent, to increase viscosity of system and water. System consists of a soluble viscosity enhancing agent with concentration from about 0.10 wt%/vol to about 2.5 wt%/vol and heat-sensitive viscosity enhancing agent with concentration from about 0.80 wt%/vol to not more than 10 wt%/vol. Soluble viscosity enhancing agent provides a composition with additional viscosity, which is equal to 5 cP to not more than 100 cP.
EFFECT: use of group of inventions provides higher permeability of therapeutic agent in an eye of a mammal, and reduces symptoms of dry eye.
12 cl, 2 tbl
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMIC COMPOSITION WITH HIGH CONCENTRATION OF OLOPATADINE | 2012 |
|
RU2613715C2 |
AQUEOUS PHARMACEUTICAL COMPOSITIONS, CONTAINING BORATE-POLYOL COMPLEXES | 2010 |
|
RU2563125C2 |
AQUEOUS PHARMACEUTICAL COMPOSITIONS CONTAINING BORATE-POLYOL COMPLEXES | 2009 |
|
RU2477631C2 |
OPHTHALMIC COMPOSITIONS | 2020 |
|
RU2798842C1 |
SELF-PRESERVED WATER PHARMACEUTICAL COMPOSITIONS | 2007 |
|
RU2436568C2 |
PHARMACEUTICAL COMPOSITION CONTAINING FLUOROQUINOLONE ANTIBIOTIC DRUG | 2009 |
|
RU2494727C2 |
KETOROLAC TROMETHAMINE COMPOSITIONS FOR TREATMENT OR PREVENTION OF OCULAR PAIN | 2009 |
|
RU2431469C1 |
Pharmaceutical composition based on tramadol for ophthalmic use | 2016 |
|
RU2744570C2 |
LIPID-BASED OPHTHALMIC EMULSION | 2019 |
|
RU2793333C2 |
NON-INVASIVE MEDICINE DELIVERY TECHNIQUE USING EYE INLAY | 2017 |
|
RU2749426C2 |
Authors
Dates
2016-10-27—Published
2012-04-19—Filed